Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00803920 · ClinicalTrials.gov registry record
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 8
- Enrollment target
NCT00803920 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 8 participants.
The verdict
NCT00803920 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The purpose of this substudy is to obtain CGM data from individuals taking exenatide. The CGM measurements gathered before starting and during treatment with exenatide IR and/or exenatide LAR will help determine the characteristics of glucose control during treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2006-12 |
| Est. Completion | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00803920
The ClinicalTrials.gov registry entry for NCT00803920 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00803920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00803920 about?
NCT00803920 is a clinical study titled "Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide". The purpose of this substudy is to obtain CGM data from individuals taking exenatide. The CGM measurements gathered before starting and during treatment with exenatide IR and/or exenatide LAR will help determine the characteristics of glucose control during treatment.
What is the current status of trial NCT00803920?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2006-12. Estimated completion is 2008-02.
Who is sponsoring clinical trial NCT00803920?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.